Panel de control de cohortes

La misión del GP2 es comprender la arquitectura genética de la enfermedad de Parkinson (EP) mediante el genotipado de grupos de pacientes diversos y el estudio de formas de la EP de las cuales se sospecha que son monogénicas. Para apoyar esta misión, seguimos recopilando cohortes diversas de todo el mundo a través de la colaboración y compartiendo datos, procesos y resultados de manera abierta. Explore el siguiente panel de control, donde encontrará los logros alcanzados hasta la fecha, y vuelva a visitar esta página periódicamente, ya que actualizamos los datos trimestralmente.

Datos globales totales

Ubicaciones únicas

Cohortes

Muestras pendientes

Muestras completadas

Última actualización: 9 de septiembre del 2021 | Diseño original del equipo GP2 Hackathon 2021: Mary Makarious, Kajsa Brolin, Yeajin Song y Anastasia Illarionova

Showing 10 of 227 cohort studies.

C-OPN

University of Calgary/McGill University | Calgary, Canada

Access Data on AMP® PD

Number of Samples Completed and Expected

Case Samples

384 Completed out of 1,500 Expected

Non-PD Samples

0 Completed out of 0 Expected

Total Samples

384 Completed out of 1,500 Expected

Ancestry Breakdown for Samples Completed

Show

Ancestry	PD Cases	Healthy Controls	Parkinson's Adjacent Disorders	Prodomal	Total Non-PD Samples
aac - african admixed	0	0	0	Pending	0
afr - african ancestry	0	0	0	Pending	0
fin - finnish population isolate	2	0	0	Pending	0
aj - ashkenazi jewish	9	0	0	Pending	0
amr - latino and indigenous people of the americas	4	0	0	Pending	0
eur - general european ancestry	348	0	0	Pending	0
eas - east asian ancestry	6	0	0	Pending	0
sas - south asian ancestry	7	0	0	Pending	0
cas - central asian ancestry	0	0	0	Pending	0
mde - middle eastern ancestry	7	0	0	Pending	0
cah - complex admixture history	1	0	0	Pending	0
total	384	0	0	0	0
Total for all completed samples					384

CALYPSO

University College London | London, United Kingdom

Access Data on AMP® PD

Number of Samples Completed and Expected

Case Samples

179 Completed out of 400 Expected

Non-PD Samples

0 Completed out of 200 Expected

Total Samples

179 Completed out of 600 Expected

Ancestry Breakdown for Samples Completed

Show

Ancestry	PD Cases	Healthy Controls	Parkinson's Adjacent Disorders	Prodomal	Total Non-PD Samples
aac - african admixed	0	0	0	Pending	0
afr - african ancestry	2	0	0	Pending	0
fin - finnish population isolate	0	0	0	Pending	0
aj - ashkenazi jewish	1	0	0	Pending	0
amr - latino and indigenous people of the americas	0	0	0	Pending	0
eur - general european ancestry	173	0	0	Pending	0
eas - east asian ancestry	0	0	0	Pending	0
sas - south asian ancestry	1	0	0	Pending	0
cas - central asian ancestry	1	0	0	Pending	0
mde - middle eastern ancestry	0	0	0	Pending	0
cah - complex admixture history	1	0	0	Pending	0
total	179	0	0	0	0
Total for all completed samples					179

Cambridge Parkinson's Research Clinic

University of Cambridge | Cambridge, United Kingdom

Number of Samples Completed and Expected

Case Samples

0 Completed out of 250 Expected

Non-PD Samples

0 Completed out of 0 Expected

Total Samples

0 Completed out of 250 Expected

CamPaIGN

University of Cambridge | Cambridge, United Kingdom

Number of Samples Completed and Expected

Case Samples

0 Completed out of 142 Expected

Non-PD Samples

0 Completed out of 0 Expected

Total Samples

0 Completed out of 142 Expected

CANDAS

University College London | London, United Kingdom

Number of Samples Completed and Expected

Case Samples

0 Completed out of 244 Expected

Non-PD Samples

0 Completed out of 18 Expected

Total Samples

0 Completed out of 262 Expected

Central Asian and Transcaucasian PD (CAT-PD)

University College London | Almaty, Kazakhstan

Access Data on AMP® PD

Number of Samples Completed and Expected

Case Samples

61 Completed out of 200 Expected

Non-PD Samples

0 Completed out of 200 Expected

Total Samples

61 Completed out of 400 Expected

Ancestry Breakdown for Samples Completed

Show

Ancestry	PD Cases	Healthy Controls	Parkinson's Adjacent Disorders	Prodomal	Total Non-PD Samples
aac - african admixed	0	0	0	Pending	0
afr - african ancestry	0	0	0	Pending	0
fin - finnish population isolate	0	0	0	Pending	0
aj - ashkenazi jewish	0	0	0	Pending	0
amr - latino and indigenous people of the americas	0	0	0	Pending	0
eur - general european ancestry	10	0	0	Pending	0
eas - east asian ancestry	1	0	0	Pending	0
sas - south asian ancestry	0	0	0	Pending	0
cas - central asian ancestry	42	0	0	Pending	0
mde - middle eastern ancestry	6	0	0	Pending	0
cah - complex admixture history	2	0	0	Pending	0
total	61	0	0	0	0
Total for all completed samples					61

Central Asian and Transcaucasian PD (CAT-PD) - Avicena Tajik State Medical University

Avicena Tajik State Medical University | Dushanbe, Tajikistan

Number of Samples Completed and Expected

Case Samples

Pending

Non-PD Samples

Pending

Total Samples

0 Completed out of 0 Expected

Central Asian and Transcaucasian PD (CAT-PD) - Istanbul Klinic

Istanbul Klinic | Baku, Azerbaijan

Number of Samples Completed and Expected

Case Samples

Pending

Non-PD Samples

Pending

Total Samples

0 Completed out of 0 Expected

Central Asian and Transcaucasian PD (CAT-PD) - Kazakh National Medical University

Kazakh National Medical University | Almaty, Kazakhstan

Number of Samples Completed and Expected

Case Samples

Pending

Non-PD Samples

Pending

Total Samples

0 Completed out of 0 Expected

Central Asian and Transcaucasian PD (CAT-PD) - Somnus Movement Disorders Clinic

Somnus Movement Disorders Clinic | Yerevan, Armenia

Number of Samples Completed and Expected

Case Samples

Pending

Non-PD Samples

Pending

Total Samples

0 Completed out of 0 Expected

Solicitar conjunto de datos de AMP-PD

Una vez que el GP2 completa el genotipado de una cohorte, todos los datos se comparten en la plataforma segura AMP® PD. Regístrese para solicitar acceso a estos datos.

Aportar una cohorte

Si desea colaborar con el GP2, póngase en contacto con nosotros para aportar una cohorte o infórmese sobre cómo hacerse miembro.

Conozca los miembros del GP2 de todo el mundo

Explore las organizaciones miembro que hacen que nuestra investigación sea posible gracias a su colaboración y contribución de muestras y datos.